4.7 Article

Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study

Gianna Vargas Centanaro et al.

Summary: This study is an observational research on the long-term outcomes and recovery of COVID-19 lung injury. Twelve months after infection, almost half of severe cases showed evidence of pulmonary fibrosis, and nearly one-third of the cases had abnormal pulmonary function. These results emphasize the importance of systematic follow-up and appropriate management of pulmonary sequelae in severe COVID-19 patients.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19

Rosario Lopez-Rodriguez et al.

Summary: Rare genetic variants in certain genes were found in COVID-19 patients under 65 years who required intubation or resulted in death, potentially influencing the severity of COVID-19 through mechanisms related to immune response and blood coagulation.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?

Naoki Yamamoto et al.

Summary: Individuals with comorbidities are more susceptible to severe cases of COVID-19 after infection with SARS-CoV-2, possibly due to genetic polymorphisms such as those of the angiotensin-converting enzyme 1 (ACE1) gene, which may increase their risk. However, there is still debate surrounding the association between ACE1 D/I polymorphism and comorbidities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Letter Cardiac & Cardiovascular Systems

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort

Nuno Faria et al.

RESPIRATORY MEDICINE (2021)

Article Multidisciplinary Sciences

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

Lukas Wettstein et al.

Summary: This study identifies alpha (1)-antitrypsin (alpha (1)AT) as an inhibitor of SARS-CoV-2 entry by binding and inactivating the serine protease TMPRSS2, which primes the virus spike protein for membrane fusion. Alpha (1)AT suppresses viral replication and may have therapeutic potential for COVID-19 treatment.

NATURE COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale

I Ferrarotti et al.

Summary: The study found that patients with severe AAT deficiency are at a higher relative risk for symptomatic SARS-CoV-2 infection, particularly those with pre-existing lung diseases. However, the death rate among these patients is similar to that of the general population.

RESPIRATORY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 infection in alpha1-antitrypsin deficiency

Carolin Schneider et al.

Summary: The study evaluated the association between Alpha1-antitrypsin deficiency and SARS-CoV-2 infection in the UK Biobank, finding that mild AATD genotypes were not associated with increased infection rates or fatalities, while the low numbers of severe AATD cases prevented definitive conclusions from being drawn.

RESPIRATORY MEDICINE (2021)

Article Respiratory System

Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population

Sabina Janciauskiene et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2020)

Article Respiratory System

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Wei-jie Guan et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Letter Cardiac & Cardiovascular Systems

An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients

Jing-Zhang Wang et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)

Letter Medicine, General & Internal

Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy

Oliver J. McElvaney et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Critical Care Medicine

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Medicine, General & Internal

Presence of Genetic Variants Among Young Men With Severe COVID-19

Caspar I. van der Made et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Immunology

Immunogenetic Association Underlying Severe COVID-19

Kendall McCoy et al.

VACCINES (2020)

Article Multidisciplinary Sciences

SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection

Nils C. Gassen et al.

NATURE COMMUNICATIONS (2019)

Article Physiology

Impact of HIV infection on α1-antitrypsin in the lung

Sarah E. Stephenson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)

Letter Critical Care Medicine

Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia

Cormac McCarthy et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Respiratory System

The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort

Christopher L. Sanders et al.

COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)

Article Respiratory System

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide

Ignacio Blanco et al.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)

Article Respiratory System

α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke

Reena Berman et al.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)

Article Pathology

Neutrophil Elastase Contributes to Acute Lung Injury Induced by Bilateral Nephrectomy

Tomoko Ishii et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Article Biochemistry & Molecular Biology

α1-Antitrypsin, old dog, new tricks -: α1-Antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevatin cAMP

Sabina M. Janciauskiene et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Pathology

α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis

Irina Petrache et al.

AMERICAN JOURNAL OF PATHOLOGY (2006)

Article Gastroenterology & Hepatology

High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran

M Hashemi et al.

HEPATOLOGY RESEARCH (2005)